Jasper Therapeutics, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – JSPR
(NASDAQ:JSPR), LOS ANGELES, Oct. 30, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against Jasper Therapeutics, Inc. (“Jasper” or “the Company”) (NASDAQ: JSPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. […]